AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,960.00p
   
  • Change Today:
    -64.00p
  • 52 Week High: 12,294.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.22m
  • Volume: 162,158
  • Market Cap: £169,904m
  • RiskGrade: 123

Latest ShareCast News

London close: Stocks finish lower as ECB stands pat

By Josh White

Date: Thursday 11 Apr 2024

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

AstraZeneca to hike 2024 dividend by 7%

By Benjamin Chiou

Date: Thursday 11 Apr 2024

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

AstraZeneca's Enhurtu cancer gets US green light for adult patients

By Frank Prenesti

Date: Monday 08 Apr 2024

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

AstraZeneca announces positive lung cancer treat... 05-Apr-2024 ShareCast
US FDA gives green light for use of AstraZeneca'... 02-Apr-2024 ShareCast
London close: Stocks turn red on return from Eas... 02-Apr-2024 ShareCast
AstraZeneca gets FDA approval for Ultomiris trea... 25-Mar-2024 ShareCast
AstraZeneca to buy US-listed Fusion Pharma for $... 19-Mar-2024 ShareCast
AstraZeneca snaps up rare disease specialist Amo... 14-Mar-2024 ShareCast
AstraZeneca's chemo replacement treatment moves ... 04-Mar-2024 ShareCast
AstraZeneca's blood-disorder drug recommended fo... 26-Feb-2024 ShareCast
AstraZeneca acquires US-based biopharmaceutical ... 20-Feb-2024 ShareCast
London close: Stocks manage gains on globally qu... 19-Feb-2024 ShareCast
AstraZeneca's Tagrisso gains FDA approval 19-Feb-2024 ShareCast
Barclays sees "compelling" entry point at AstraZ... 12-Feb-2024 ShareCast
London close: Stocks slip as US jobless claims f... 08-Feb-2024 ShareCast
AstraZeneca shares slip as Q4 profits miss forec... 08-Feb-2024 ShareCast
London close: Stocks finish lower as wage growth... 16-Jan-2024 ShareCast
UBS downgrades AstraZeneca to 'sell' 16-Jan-2024 ShareCast
London close: Stocks fall amid rising geopolitic... 03-Jan-2024 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,960.00p
Change Today -64.00p
% Change -0.58 %
52 Week High 12,294.00
52 Week Low 9,501.00
Volume 162,158
Shares Issued 1,550.22m
Market Cap £169,904m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.01% below the market average91.01% below the market average91.01% below the market average91.01% below the market average91.01% below the market average
92.45% below the sector average92.45% below the sector average92.45% below the sector average92.45% below the sector average92.45% below the sector average
Price Trend
19.66% above the market average19.66% above the market average19.66% above the market average19.66% above the market average19.66% above the market average
71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average
Income
86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Growth
81.35% above the market average81.35% above the market average81.35% above the market average81.35% above the market average81.35% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average

What The Brokers Say

Strong Buy 8
Buy 12
Neutral 6
Sell 0
Strong Sell 2
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 22-Feb-24 10-Aug-23
Paid 25-Mar-24 11-Sep-23
Amount 197.00¢ 93.00¢

Trades for 16-Apr-2024

Time Volume / Share Price
09:09 59 @ 10,960.00p
09:09 275 @ 10,958.00p
09:09 34 @ 10,958.00p
09:09 141 @ 10,958.00p
09:09 14 @ 10,958.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page